HCPCS Code S0034: Injection, ofloxacin 400 mg billing guide

HCPCS Code S0034 is the Level II billing code for injection of ofloxacin, 400 mg. Medicaid managed care plans and commercial insurers use it to reimburse this injectable fluoroquinolone antibiotic. Medicare does not recognize it.

Billers reach for S0034 when treating urinary tract infections, pelvic inflammatory disease, and other bacterial infections that call for injectable therapy. One unit covers one 400 mg dose, and the claim needs an ICD-10 code that names the infection treated.

Found our content helpful?

Key takeaways

HCPCS Code S0034 covers injection of ofloxacin, 400 mg, and sits in the S-series of temporary national codes. The S-series was established by the Blue Cross Blue Shield Association and the Health Insurance Association of America, now part of AHIP.

Medicare does not reimburse S-series codes. S0034 is accepted by Medicaid managed care and most commercial insurers, though acceptance varies by state and individual plan.

Bill one unit per 400 mg dose and pair S0034 with an ICD-10 diagnosis code that documents the bacterial infection requiring ofloxacin treatment.

Practice management software like Pabau flags payer-specific coverage rules at the point of care, which cuts denials on codes like S0034.

HCPCS Code S0034: Definition and official code details

HCPCS Code S0034 is a Level II temporary national code that describes the injection of ofloxacin at a dosage of 400 mg per administration. The code sits in the S-series section of the Healthcare Common Procedure Coding System (HCPCS). That section covers drugs, biologicals, and supplies used primarily in non-Medicare settings.

According to the Centers for Medicare and Medicaid Services (CMS), S-codes are classified as temporary national codes. They sit outside the permanent HCPCS Level II code set that CMS maintains.

The unit of service is one unit per 400 mg dose. Payers may require quantity reporting when several doses are administered in a single encounter. Verify each plan’s billing manual before submitting.

Drug information: Ofloxacin 400 mg injection

Ofloxacin is a broad-spectrum fluoroquinolone antibiotic approved by the FDA for treatment of several bacterial infections. The injectable formulation is used when oral therapy is not feasible or when rapid systemic coverage is required.

Availability is the practical constraint on this code. Floxin IV, the branded injectable formulation, has been discontinued in the US, and injectable ofloxacin is largely unavailable on the domestic market. Confirm supply with your pharmacy before you build a treatment protocol around the injection.

Clinicians administering ofloxacin by injection should document the route and the clinical rationale in the patient record. That record is what supports medical necessity at billing time.

FDA-approved indications for ofloxacin relevant to injectable use include the following:

• Urinary tract infections (UTIs) caused by susceptible organisms, including complicated UTIs requiring injectable therapy
• Pelvic inflammatory disease (PID) as part of a combination regimen for serious pelvic infections
• Lower respiratory tract infections including community-acquired pneumonia and acute bacterial exacerbations of chronic bronchitis
• Skin and skin-structure infections caused by methicillin-susceptible Staphylococcus aureus, Streptococcus pyogenes, or Proteus mirabilis
• Prostatitis caused by Escherichia coli, where an injectable course may precede oral step-down therapy

Ofloxacin carries an FDA Boxed Warning for serious adverse effects including tendinitis, tendon rupture, peripheral neuropathy, and CNS effects. Document the clinical decision to use a fluoroquinolone over alternative agents, particularly in patients with known risk factors.

Payer coverage: Medicare, Medicaid, and commercial insurance

Payer coverage for S0034 splits across three groups, and that split decides which code you submit. Knowing where the patient’s plan sits before the drug is administered is the single most useful step toward a clean claim. The chart below maps each payer group to the code it accepts.

Medicare non-coverage of S-codes

Medicare does not reimburse S-series HCPCS codes, because CMS does not maintain them. CMS manages the permanent national HCPCS Level II codes, the A through V codes, and the S-series sits outside that structure. When treating Medicare fee-for-service patients with ofloxacin injection, billers have two practical options:

• Use a permanent-set code instead, either J3490 (unclassified drugs) or J3590 (unclassified biologics), and include a drug invoice with the claim
• Bill the drug as part of a facility encounter under the applicable revenue code if the setting qualifies

Submitting an S-code against a Medicare patient is one of the faster routes to a denial. Expect CO-96, the non-covered charge code, or a related remark such as CO-B7 or CO-204. Routing Medicare claims down the correct path from the start keeps recoverable denials from aging into write-offs.

Billing guidelines for S0034

Accurate billing for S0034 rests on the unit of service, the diagnosis code, and the payer’s acceptance of S-series codes. Work through these steps before you submit any claim for ofloxacin injection.

1. Confirm payer acceptance. Before administering or coding S0034, verify the patient’s plan accepts S-series codes. Commercial and Medicaid managed care plans typically do. Medicare fee-for-service does not. Pull the payer’s most recent fee schedule or billing manual to confirm.
2. Report one unit per 400 mg dose. The unit of service for S0034 is per 400 mg injection. If the patient receives a single 400 mg dose, report quantity 1. If clinical protocol calls for a different total dose, calculate units accordingly and document the dosage in the medical record.
3. Select the appropriate ICD-10 diagnosis code. Pair S0034 with an ICD-10-CM code that reflects the bacterial infection being treated. See the ICD-10 pairing table in the next section for the most commonly linked diagnosis codes.
4. Place it on the CMS-1500 or 837P claim. Report S0034 in box 24D with the appropriate modifier if the payer requires one. Place the NDC for the specific ofloxacin product in the associated narrative field when the payer requires drug-level reporting.
5. Include the drug invoice. Many commercial payers require an invoice or label confirming the drug, lot number, and dosage when billing injectable drugs. Attach it, or make it available for post-claim audit.
6. Submit a clean claim. Run the claim against the payer’s edits before transmission, and check it meets every clean claim requirement. S-code rejections are most often caused by missing NDC numbers, incorrect units, or missing prior-authorization numbers.

ICD-10 diagnosis codes commonly paired with S0034

Choosing the right diagnosis code is required to establish medical necessity for the ofloxacin injection. The ICD-10-CM codes below are the ones most frequently linked to S0034, based on ofloxacin’s FDA-approved indications. Confirm the specific code against the patient’s documented clinical findings, not just the drug administered.

Use the most specific ICD-10-CM code the clinical documentation supports. Vague codes raise the risk of a medical-necessity denial, particularly with commercial injectable drug policies that require a documented infection type. The full ICD-10-CM code index lists every genitourinary and respiratory code these pairings draw from.

Understanding HCPCS Level II S-codes

The S-series sits within HCPCS Level II but operates differently from the permanent national codes that CMS maintains. Knowing the structure helps billers answer coverage questions and pick the right code when a drug has both a permanent code and an S-series alternative.

• Maintained by the insurance industry: The S-series was established jointly by the Blue Cross Blue Shield Association and the Health Insurance Association of America. That association is now part of AHIP, which administers the codes today. AHIP updates them on a cycle separate from the annual CMS HCPCS update.
• Non-Medicare use only: CMS explicitly excludes S-codes from Medicare billing. Submitting S-codes against Medicare fee-for-service claims results in automatic rejection, not just a denial that can be appealed.
• Primarily Medicaid managed care and commercial: S-codes give Medicaid managed care organizations (MCOs) and commercial insurers a standardized way to report drugs and services. They cover items the permanent HCPCS set leaves out.
• Not subject to CMS fee schedules: Because CMS does not maintain S-codes, there is no national Medicare payment rate for S0034 or any other S-code. Payment rates are set by individual Medicaid MCO contracts and commercial plan fee schedules.
• Verify coverage annually: S-code acceptance policies change when state Medicaid programs revise their MCO contracts or when commercial payers update their formularies. Verify HCPCS code acceptance with each payer at least annually.

Related HCPCS codes for injectable antibiotics

S0034 does not always apply, most often because the payer rejects S-codes. Billers then reference an adjacent S-series code, or fall back to the permanent unclassified drug codes. The table below lists the most relevant codes in context.

When billing J3490 as a fallback, always include the drug name, dosage, and NDC in the claim narrative. Payers use this information to cross-reference the drug invoice and price the claim correctly. Treat the narrative field as a required element rather than optional text.

Documentation requirements and compliance tips

Thin documentation is the leading cause of post-payment audits and denials for injectable drug codes. A claim for S0034 can clear front-end edits and still be recouped in a retrospective audit. The deciding factor is whether the medical record supports the service billed.

• Medical necessity statement: The clinical note must explain why ofloxacin injection was selected over an oral fluoroquinolone. Acceptable reasons include inability to tolerate oral medication, a presentation requiring rapid systemic coverage, or existing IV access. Document that rationale in the assessment and plan.
• Route of administration: Record whether the drug was administered intravenously or intramuscularly. The code descriptor specifies injection without limiting the route, but payers may request route documentation during review. Note the infusion rate and access site for IV administration.
• Dosage and lot number: Record the exact dose administered, the drug’s lot number, and the expiration date. One unit of S0034 equals 400 mg. Many Medicaid MCO audits request the lot number to confirm the drug billed matches the drug dispensed.
• Prescriber authorization: Injectable antibiotics require a documented order from an authorized prescriber. The order should appear in the patient record with a date and signature that predate the administration.
• Patient response note: For multi-day injectable courses, include a brief daily progress note covering patient response and any adverse effects. Record the plan to continue or discontinue the drug. Payers use these notes to confirm ongoing medical necessity.

Practices that struggle with consistent documentation usually need a structured intake and clinical note workflow. Documentation standards have to be applied at the point of care rather than reconstructed after the fact. Building the required data points into a standard note template is the most reliable way to keep injectable drug claims audit-ready.

How claims management software keeps S0034 off the denial list

Most practices catch an S-code problem after the remittance arrives. The biller submits S0034, the Medicare claim rejects, and someone reworks it weeks later from a thin memory of the encounter.

Practice management software like Pabau moves that check to the front of the process. Payer rules sit against each plan record, so the biller sees whether the plan takes S-series codes. That check happens while the ofloxacin injection is being coded, before the claim leaves the practice.

Drug details captured in the clinical note carry through to the claim without re-entry. Dose, route, lot number and NDC land in the same record an auditor will later ask for.

The outcome is fewer reworked claims and a shorter path from encounter to payment. Pabau’s claims management software keeps the supporting documentation attached to the claim. A retrospective audit then does not send staff hunting through paper files.

Reduce billing denials with smarter claim management

Pabau’s claims management software helps practices configure payer-specific rules, flag non-covered codes before submission, and keep injectable drug billing compliant across Medicaid and commercial plans.

Book a demo

Conclusion

S0034 is a simple code to bill correctly and an easy one to bill at the wrong payer. The Medicare exclusion and the state-by-state Medicaid variation cause most of the denials this code produces.

Decide the code before the dose is given, not after the remittance comes back. Check the plan’s acceptance of S-series codes and report one unit per 400 mg. Attach the ICD-10 code that names the infection being treated. Practices that build that check into the encounter rarely meet this code again in a denial queue.

Book a demo to see how Pabau flags a non-covered code before the claim is submitted.

Continue your research

Need to understand how clean claims reduce S-code rejections? What is a clean claim covers the documentation and formatting standards that prevent front-end rejections on injectable drug codes.

Want a structured approach to denial prevention? Denial management in healthcare outlines how to categorize, track, and appeal claim rejections, including those from S-code submissions.

Trying to decode a rejection on the remittance? Denial codes in medical billing explains what CO-96 and its neighbours mean and what each one asks you to do next.

Looking for guidance on the broader billing process? What is revenue cycle management explains how injectable drug billing fits into the end-to-end financial workflow for clinical practices.

New to the mechanics behind the claim? What is medical billing walks through the steps between the encounter and the payment that codes like S0034 sit inside.

Frequently asked questions